The mother of Billy Caldwell, a Northern Ireland child with epilepsy denied access to medicinal cannabis, has hit out at the links between Theresa May’s husband and companies which supply the drug.
The Daily Mirror reports Philip May’s Capital Group is the largest investor in GW Pharmaceuticals, which produces cannabis oil – which Billy Caldwell had been using for his treatment – for sale in a foreign market.
Speaking to the paper, Billy’s mother Charlotte Caldwell said: “Why is my son being left to die in his own country by his own government? I can tell you why, greed and hypocrisy and it’s a recipe that will kill Billy.”
Billy Caldwell requires cannabis oil to prevent seizures.
UK-based cannabis-legalisation group United Patients Alliance reported in April GW Pharmaceuticals has produced a medicine extracted from the raw cannabis plant called Sativex, used for Multiple Sclerosis patients, as well as Epidiolex, which is made using purified cannabinoid (a component part of cannabis) CBD.
It also highlighted that husband of UK Home Office minister Victoria Atkins is a managing director of British Sugar which grows raw cannabis to supply GW to manufacture Epidolex.
Victoria Atkins has previously spoken out against the legalisation of cannabis.
On Monday Home Office minister Nick Hurd refused to give a supply cannabis oil back to Charlotte Caldwell which she was attempting to bring into the country from Canada.
In 2017, 12-year-old Billy Caldwell became the first person in the UK to be proscribed cannabis oil – but last month his GP was told he could not longer make the prescription, having received a warning from the Home Office.
On Tuesday Charlotte Caldwell told ITV’s This Morning programme that hours after having medication confiscated at Heathrow Airport Billy suffered his first seizure in almost a year.
Belfast Telegraph Digital
Full story is available here.